Download HEAD_A - DVM News

Resources and References
Ek-Kommonen, et al., The Veterinary Record. Outbreak of canine distemper in vaccinated dogs
in Finland. October 11, 1997.
Klingborg, Donald J. DVM et al., JAVMA. AVMA Council on Biologic and Therapeutic
Agents’ report on cat and dog vaccines. Vol. 221, No. 10, November 15, 2002.
Spickler, Anna R., DVM, PhD. and James A. Roth, DVM, PhD., JVIM. Adjuvants in
Veterinary Medicine: Modes of Action and Side Effects. May/June 2003.
Tizzard, Ian, B.V.M.S., Ph.D. Veterinary Forum. Science vs. surmise in decisions on
vaccination frequency. January 2002.
Duval, David and Urs Giger. JVIM. Vaccine-associated immune-mediated hemolytic anemia in
the dog. Vol. 10, No. 5. September-October, 1996.
Larson, L. J., DVM. And R. D. Schultz, Ph.D. AJVR. Comparison of selected canine vaccines
for their ability to induce protective immunity against canine parvovirus infection. Vol. 58. No.
4, April 1997.
McCaw, Dudley L., DVM et al., JAVMA. Serum distemper virus and parvovirus antibody
titers among dogs brought to a veterinary hospital for revaccination. Vol. 213, No. 1, July 1,
1998.
Olson, P., et al., The Veterinary Record. Duration of antibodies elicited by canine distemper
virus vaccinations in dogs. December 20-27, 1997.
Paul, Michael A. DVM et al., Journal of the American Animal Hospital Association. Report of
the American Animal Hospital Association (AAHA) Canine Vaccine Task Force: Executive
Summary and 2003 Canine Vaccine Guidelines and Recommendations. March/April 2003.
American Association of Feline Practitioners and Academy of Feline Medicine Advisory
Panel Reports: Feline Vaccines Guidelines, 2000 and Feline Retrovirus Testing and
Management, 2001.
Gobar, Glenna M., DVM, and Philip Kass, DVM, PhD., JAVMA. World Wide Web-based
survey of vaccination practices, postvaccinal reactions, and vaccine site-associated sarcomas in
cats. Vol. 220, No. 10, May 15, 2002.
Lappin, Michael R., DVM et al., JAVMA. Use of serologic tests to predict resistance to feline
herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats. Vol. 220, January 1,
2002.
Legendre, Alfred M., DVM, MS., et al., JAVMA. Comparison of the efficacy of three
commercial feline leukemia vaccines in a natural challenge exposure. Vol. 199, No. 10,
November 15, 1991.
Schultz RD, Scott FW. Canine and feline immunization. Vet Clin North Am 1978;8(4):755768.
American Association of Feline Practitioners: 2000 Feline Vaccination Guidelines.
www.aafponline.org/about/guidelines_vaccine.pdf
Schultz RD. Current and future canine and feline vaccination programs. Vet Med
1998;93(3):233-254.
Klingborg DJ, Hustead DR, Curry-Galvin EA, et al. AVMA Council on Biologic and
Therapeutic Agents’ report on cat and dog vaccines. J Am Vet Med Assoc 2002;221(10):14011407.
Ward MP, Glickman LT, Guptill LF. Prevalence of and risk factors for leptospirosis among
dogs in the United States and Canada: 677 cases (1970-1998). J Am Vet Med Assoc
2002;220(1):53-58.
Ford, RB (ed). Vaccines and vaccinations. Vet Clin North Am Sm Anim Pract 2001;31(3).
Day MJ. Clinical immunology of the dog and cat. Ames: Iowa State University Press, 1999.
1Gershwin LJ, Krabowka S, Olson RG (ed). Immunology and immunopathology of domestic
animals, 2nd ed. St. Louis: Mosby Year Book, Inc., 1995.
1Goldsby RA, Kindt TJ, Osborne BA (ed). Kuby-immunology, 4th ed. New York: W.H.
Freeman and Co., 2000.
Janeway CA, Travers LJ, Walport M (ed). Immunobiology, 5th ed. New York: Garland
Publishing, 2001.
Pastoret PP (ed). Veterinary vaccinology. Amsterdam: Elsevier Science, 1997.
Schultz RD (ed). Veterinary vaccines and diagnostics. Advances in veterinary medicine, Vol.
41. San Diego: Academic Press, 1999.
Tizard I. Veterinary immunology, 6th ed. Philadelphia: WB Saunders and Co., 2000.
Schultz RD, Conklin S. The immune system and vaccines. Comp Cont Educ Pract Vet
1998;20:5-18.
Schultz RD. Considerations in designing effective and safe vaccination programs for dogs. In:
Recent advances in canine infectious diseases. Carmichael LE (ed), International Veterinary
Information Service, 2000. www.ivis.org
Hageny T, Larson LJ, Bonds MD, Schultz RD. Recombinant vaccines provide unique
opportunities in companion animal vaccination programs. Abstract 68P. The Conference of
Research Workers in Animal Diseases 82nd Annual Meeting, St. Louis, Missouri, 2001.
Appel MJG, Parish CR. Virus infections of carnivores. MJG Appel (ed). Elsevier, Amsterdam
1987:29-51;69-92.
Appel MJG, Gillespie JH. Canine distemper virus: Virology monographs 11. In: Hallayer GS,
Meyer KF (eds); Continuing handbook of virus research Ed. Springer-Verlag, Wier, 1972.
Greene CE, Schultz RD, Ford RB. Canine vaccination. Vet Clin North Am Sm An Pract Vet
2001;31(3):473-492.
Baker JA. Annual report of the veterinary virus research institute. Ithaca: Cornell University
Press, 1959;(9).
Piercy SE. An appraisal of the value and method of use of living attenuated canine distemper
vaccines. Vet Rec 1961;73:944-949.
Carmichael LE. Canine viral vaccines at a turning point – A personal perspective. In: Schultz
RD (ed), Advances in veterinary medicine 41: Veterinary vaccines and diagnostics. San Diego:
Academic Press, 1999:289-307.
Gillespie JH, Baker JA, Burgher J, Robson D, Gilman B. The immune response of dogs to
distemper virus. Corn Vet 1958;48:103-126.
Gorham JR. Duration of vaccination immunity and the influence on subsequent prophylaxis. J
Am Vet Med Assoc 1966;149:699-704.
Olson P, Finnsdottir H, Klingeborn B, Hedhammer A. Duration of antibodies elicited by
canine distemper virus vaccinations in dogs. Vet Rec 1977;141:654-655.
Prydie J. Persistence of antibodies following vaccination against canine distemper and effect
of revaccination. Vet Rec 1966;78:486-488.
Schultz RD. Duration of immunity to canine vaccines: What we know and don’t know. In:
Proceedings, Canine infectious diseases: From clinics to molecular pathogenesis. Cornell
University, 1999.
Larson LJ, Sawchuck S, Bonds MD, Schultz RD. Comparison of antibody titers among dogs
vaccinated 1, 2 or 3 years previously. Abstract 82P, Proceedings 80th Meeting, Conf Res Work
An Dis, Chicago, Illinois, 1999.
Larson LJ, Sawchuck S, Schultz RD. Duration of vaccinal immunity in a population of clinic
dogs. Abstract 75P, Proceedings 83rd Meeting, Conf Res Work An Dis, St. Louis, Missouri,
2002.
Tizard I, Ni YW. Use of serologic testing to assess immune status of companion animals. J
Am Vet Med Assoc 1998;213:54-60.
Woodland DL, Cole GA, Doherty PC. Viral immunity and vaccine strategies. In: Kaufmann
SH (ed). Concepts in vaccine development. Berlin: Walter de Gruyter, 1996:141-160.
Burtonboy S, Charlier P, Hertoghs J, Lobmann M, Wiseman A, Woods S. Performance of a
high titre attenuated canine parvovirus vaccine in pups with maternally derived antibody. Vet
Rec 1991;128:377-381.
Schultz RD, Ford RB, Olsen J, Scott FW. Titer testing and vaccination: A new look at
traditional practices. Vet Med 2002;97:1-13(insert).
www.aphis.usda.gov/vs/cvb/index.htm or www.aphis.gov/vs/cvb/regsandguidance.htm
Proposed Rules. Federal Register. January 15, 2002: Vol 67, No 10.
Principles of vaccination. J Am Vet Med Assoc 2001;219:575-576.
Schultz RD. Emerging issues. Proceedings Infect Gastroent Symp; Vet Learning Syst,
Lawrenceville, New Jersey, 1995:19-24.
Larson LJ, Schultz RD. Efficacy of immunity induced by canine coronavirus (CCV) vaccines
compared against immunity after natural infection with CCV. Abstract P61, Proceedings 77th
Annual Meeting, Conf Res Workers An Dis, Chicago, Illinois, 1996.
Elston T, Rodan I, Flemming D, et al. 1998 Report of the American Association of Feline
Practitioners and Academy of Feline Medicine Advisory Panel on Feline Vaccines. J Am Vet
Med Assoc 1998;212:227-241.
Greene CE. lmmunoprophylaxis and immunotherapy. In: Greene CE, ed. Infectious diseases of
the dog and cat. 2nd ed. Philadelphia: WB Saunders Co, 1998;717-750.
Pedersen NC. Basic and clinical immunology. In: Holzworth J, ed. Diseases of the cat:
medicine and surgery. Philadelphia: WB Saunders Co, 1987;146-181.
Richards JR. Feline sarcoma task-force meets. J Am Vet Med Assoc 1997;210:310-311.
Pollock RVH, Postorino NC. Feline panleukopenia and other enteric viral diseases. In:
Sherding RG, ed. The cat: diseases and clinical management. New York: Churchill Livingstone,
1994;479-487.
de Lahunta A. Comments on cerebellar ataxia and its congenital transmission in cats by feline
panleukoperna vws. J Am Vet Med Assoc 1971;158:901-906.
Scott FW. Viral diseases: panleukopenia. In: Holzworth J, ed. Diseases of the cat: medicine
and surgery. Philadelphia: WB Saunders Co, 1987;182-193.
Scott FW, Geissinger C. Duration of immunity in cats vaccinated with an inactivated feline
panleukopenua, herpesvirus, and calicivirus vaccine. Feline Pract 1997;2S(4):12-19.
Scott FW, Geissinger CM. Long-term immunity in cats vaccinated with an inactivated
trivalent vaccine. Am 1 Vet Res 1999;60:652-658.
Olson L, Larson L, Schultz R. Canine parvovirus (CPV-2b) infection in cats, in Proceedings.
Conf Res Workers Anim Dis 1998;79.
Sharp NJH, Davis BJ, Guy 1S, Cullen JM, Steingold SF, Kornegay JN. Hydranencephaly and
cerebellar hypoplasia in two kittens attributed to intrauterine parvovirus infection. J Comp Pathol
1999;121:39-53.
Wolf AM. Other feline viral diseases. In: Ettinger SJ, Peldman EC, eds. textbook of veterinary
internal medicine. 5th ed. Philadelphia: WB Saunders Co, 200u;444~453.
Ford RB. Viral upper respiratory infection in cats.
Pedersen NC. Feline calicivirus infection. In: Pedenen NC, ed. Feline infectious diseases.
Goleta, Calif: Arnencan Veterinary Publications, 1988;61-67.
Church R. Lameness in kittens after vaccination. Vet Rec 1989;125:609.
Dawson S, McArdle F, Bennett D, et al. Investigation of vaccine reactions and breakdowns
after feline calicivirus vaccination. Vet Rec 1993; 132:346-350
Tenorio AP, Franti CE, Madewell BR, Pedemen NC. Chronic oral infections of cats and their
relationship to persistent oral carriage of feline calici-, immunodeficiency, or leukernia viruses.
Vet Immuno J Immunopathol 1991;29:1-14.
Bennett D, Gaskell RM, Mills A, Knowbs J, Carter S, McArdb F. Detection of feline
calicivirus antigens in the joints of infected cats. Vet Rec 1989;124:329-332.
Reubel GH, Hoffmann DE, Pedersen NC Acute and chronic faucitis of domeshc cats. A feline
calicivirus induced disease. Vet Clin North Am Small Anim Pract 1992;22:1347-1360.
Dawson S, Bennen D, Carter SD, et al. Acute arthritis of cats associated with feline calicivirus
infection. Res Vet Sci 1994;56:133-143.
Johnson RP, Povey RC. Vaccination against feline vira rhinotracheitis in kittens with
maternally derived feline viral rhinotracheids antibodies. J Am Vet Med Assoc 1985;186:149152.
Dawson S, Gaskell RM. Problems with respiratory virus vaccination in cats. Compend Contin
Educ Prac! Ve'1993;15:1347-1354.
Krebs 1W, Smith JS, Rupprecht CE, Childs JE. Rabies surveillance in the United States
during 1997. J Am Vet Med Assoc 1998;213:1713-1728.
Greene CE, Dreesen DW. Rabies. In: Greene CE, ed. Infectious diseases of the dog and cat.
2nd ed. Philadelphia: WB Saunders Co, 1998;114-126.
Jenkins SR, Auslander M, Conti L, Johnson RH, Leslie MJ, Sorhage FE. Compendium of
animal rabies prevention and control, 2000. J Am Vet Med Assoc 2000;216:338-343.
Kass PH, Barnes WG, Spangler WL, Chomel BB, Culbertson MR. Epidemiologic evidence
for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet Med
Assoc 1993;203:396-405.
Macy DW, Hendrick MJ. The potential role of inflammation in the development of
postvaccinal sarcomas in cats. Vet Clin North Am Small Anim Pract 1996;26: 103-109.
Macy DW, Chretin J. Local postvaccinal reactions of a recombinant rabies vaccine. Vet
Forum 1999;16:44-49.
Levy JK. FeLV and non-neoplastic FeLV-related disease. In: Ettinger SJ, Feldman EC, eds.
Textbook: of veterinary internal medicine. 5th ed. Philadelphia: WB Saunders Co, 2000;424-432.
Hoover EA, Olsen RG, Hardy WD Jr, Schaller JP, Mathes LE. Feline leukemia virus
infection: age-related variation in response of cats to experimental infection. J Natl Cancer Inst
1976;57:365-369.
Sparkes AH. Feline leukemia virus—a review of immunity and vaccination. J Small Anim
Pract 1997;38:187-194.
Edwards D, Elston T, Loar A, et al. American Association of Feline Practitioners and the
Academy of Feline Medicine recommendations for feline leukemia virus testing and
recommendations for feline immunodeficiency virus testing. Albuquerque: American
Association of Feline Practitioners, 1996.
Ford RB, Levy JK. Infectious diseases of the respiratory tract. In: Sherding RG, ed. The cat:
diseases and clinical management. New York: Churchill -Livingstone, 1994;489-500.
Sykes JE, Anderson GA, Studdert VP, Browning GF. Prevalence of feline Chlamydia psittaci
and feline herpesvirus 1 in cats with upper respiratory tract
disease. J Vet Intern Med
1999;13:153-162,
Wills J, Howard P, Gruffydd-Jones T, Wathes C. Prevalence of Chlamydia psittaci in different
cat populations in Britain. J Small Anim Pract 1988;29:327-339.
Starr RM. Reaction rate in eats vaccinated with a new controlled-titer feline panleukopeniarhinotracheitis-ealicivirus-Chlamydia psittaci vaccine. Cornell Vet 1993;83:311-323.
Vennema H, Poland A, Hawkins KF, Pedersen NC. A comparison of the genomes of FECYs
and FlPVs and what they tell us about the relationships between feline coronaviruses and their
evolution. Feline Pract 1995;23:40 44.
Vennema H, Poland A, Foley J, Pedersen NC. Feline infectious peritonids viruses arise by
mutation from endemic feline enteric coronaviruses. Virology 1998;243: 150-157.
Pedersen NC. An overview of feline entene coronavirus and infectious pentonitis virusinfections. Feline Pract 1995;23:7-20.
Foley JE, Poland A, Carlson J, Pedersen NC. Patterns of feline coronavirus infection and fecal
shedding from cats in multiple-eat environments. J Am Vet Med Assoc 1997;210:1307-1312.
Harpold LM, Legendre AM, Kennedy MA, Plummer PJ, Millsaps K, Rohrbach B. Fecal
sbeddlng of feline eoronavirus in adult cats and kittens in an Abyssinian cattery. J Am Vet
MedAssoc 1999;215:948-951.
Foley JE, Pedersen NC. The inheritance of susceptibility to feline infectious peritonitis in
purebred catteries. Feline Pract 1996;24:14-22.
Gerber JD, Ingersoll JD, Gast AM, et al. Protection against feline infectious peritonitis by
intranasal inoculation of temperature-sensitive FIPV vaccine. Vaccine 1990;8:536-542.
Hoskins JD, Taylor HW, Lomax TL . Independent evaluation of a modified-live feline
infectious peritonids virus-vaccine under experimental conditions (Louisiana experience). Feline
Pract 1995;23:72-73.
McArdle F, Tennant B, Bennett M, Kelly DF, Gaskell CJ, Gaskell RM. Independent
evaluation of a modified live FIPV vaccine under experimental conditions (University of
Liverpool experience). Feline Pract 1995;23:67-71.
Scott FW, Corapi WV, Olsen CW. Independent evaluation of a modified-live FIPV Vaccine
under experimental conditions (Cornell experience). Feline Pract 1995;23:74-76.
Scott FW, Olsen CW, Corapi WV. Antibody-dependent enhancement of feline infectious
peritonitis virus infection. Feline Pract l99S;23:77-80.
Addie DD, Jarrett O. A study of naturally occurring feline coronavirus infections in kittens.
Vet Rcc 1992;130:133-137.
Moriello KA, DeBoer DJ. Dematophytosis: advances in therapy and control. In: August JR,
ed. Consultations in feline internal medicine. 3rd ed. Philadelphia: WB Saunders Co, 1997;177190.
Coutts AJ, Dawson S, Binns S, Hart CA, Gaskell CJ, Gasltell RM. Studies on natural
transmission of Bordenila bronchiscptica in cats. Vet Microbiol 1996;48:19-27.
Welsh RD. Bordetella bronchiscptica infections in cats.
J Am Anim Hosp Assoc
1996;32:153-158.
Speakman AJ, Dawson S, Binns SH, Gaskell CJ, Hart CA, Gaskell RM. Bordetella
bronchseptica infection in the cat. J Small Anim Pract 1999;40:252-256.
Pedersen NC. Common infectious diseases of multi-cat environments. In: Pratt PW, ed. Feline
husbandry: diseases and management in the mult-cat environment. Goleta. Calif: American
Veterinary Publications, 1991;163-288.
Bergam JE, Vernooij J, Zegers EM. Prevalence of antibodies against Bordetella
bronchiseptica in catas with a history of respiratory disease. Vet quart 19997;19:S50-S51.
McArdle HC, Dawson S, coutts AJ, et al. Seroprevalence and isolation rate of Bordetella
bronchiseptica in cats in the UK. Vet Rec 1994;135:506-507.
Hoslins JD, Williams J, Roy AF, Peters JC, McDonough P. Isolation and characterization of
Bordetella bronchiseptica from cats in southern Lousiana. Vet Immunol Immunopathol
1998;65:173-176.
Binns SH, Dawson S, Speakman AJ, et al. Prevalence and risk factors for feline Bordetella
bronchiseptica infection. Vet Rec 1999;144:575-580.
Leib MS, Zajac AM. Giardiasis in dogs and cats. Vet Med 1999;94:793.
Zajac AM. Giardiasis. In: August JR, ed. Consultations in feline internal medicine. 2 nd ed.
Philadelphia: WB Saunders Co, 1994;83-86.
Zajac AM. Giardiasis. Compend Contin Educ Pract Vet 1992;14:604-611.
Leib MS, Zajac AM. Giardia: diagnosis and treatment. In: Bonagura JD, Kirk RW, eds.
Current veterinary therapy XII. Philadelphia: WB Saunders Co, 1995;716-720.
Lappin MR. Protozoal and miscellaneous infections. In: Ettinger SJ, Feldman EC, eds.
Textbook of veterinary internal medicine. 5th ed. Philadelphia: WB Saunders Co, 2000;408-417.
Barr SC. Enteric protozoal infections. In: Greene CE, ed. Infectious diseases of the dog and
cat. 2nd ed. Philadelphia: WB Saunders Co, 1998;482-291.
Bowman D. Feline giardiasis. CFHC Information Bulletin 1994;13:1-3.
Espeseth DA, Myers TJ. Authorities and procedures for licensing veterinary biological
products in the United States. In: Schultz RD, ed. Veterinary vaccines and diagnostics. San diego
Calif: Academic Press 1999;585-593.
Hustead Dr. why do vaccine labels say the funny things they do? In: Schultz RD, ed.
Veterinary vaccine and diagnostics. San Diego, Calif: Academic Press, 1999;633-641.
Baker JA. Annual report of the Veterinary Virus Research Institute. Ithaca, NY: Cornell
University 1959.
Piercy SE. An appraisal of the value and method of use of living attenuated canine distemper
vaccines. Vet Rec 1961;73:944-949.
Povey RC, Koones H, Hays MB. Immunogenicity and safety of an inactivated vaccine for the
prevention of rhinotracheitis, caliciviral disease, and panleukopenia in cats. J Am Vet Med Assoc
1980;177:347-350.
Lappin MR, Jensen W, Andrew J, et al. Prediction of resistance to panleukopenia, herpesvirus
1 and calcicvirus infections utilizing serology. J Am Vet Med Assoc 2000:submitted for
publication.
Macy DW. Vaccination against feline retroviruses. In: August JR, ed. Consultations in feline
internal medicine. 2nd ed. Philadelphia: WB Saunders Co, 1994;33-40.